Works matching IS 03065251 AND DT 1986 AND VI 21 AND IP S2
1
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 129S, doi. 10.1111/j.1365-2125.1986.tb02862.x
- Article
2
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 161S, doi. 10.1111/j.1365-2125.1986.tb02866.x
- Nicholson, JP;
- Resnick, LM;
- Laragh, J
- Article
3
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 97S, doi. 10.1111/j.1365-2125.1986.tb02859.x
- Article
4
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 123S, doi. 10.1111/j.1365-2125.1986.tb02861.x
- Article
5
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 155S, doi. 10.1111/j.1365-2125.1986.tb02865.x
- Article
6
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 183S, doi. 10.1111/j.1365-2125.1986.tb02869.x
- Article
7
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 109S, doi. 10.1111/j.1365-2125.1986.tb02860.x
- Article
8
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 197S, doi. 10.1111/j.1365-2125.1986.tb02871.x
- Article
9
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 149S, doi. 10.1111/j.1365-2125.1986.tb02864.x
- Follath, F;
- Ha, HR;
- Schutz, E;
- Buhler, F
- Article
10
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 173S, doi. 10.1111/j.1365-2125.1986.tb02868.x
- Article
11
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 191S, doi. 10.1111/j.1365-2125.1986.tb02870.x
- Article
12
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 143S, doi. 10.1111/j.1365-2125.1986.tb02863.x
- Muller, FB;
- Ha, HR;
- Hotz, H;
- Schmidlin, O;
- Follath, F;
- Buhler, FR
- Article
13
- British Journal of Clinical Pharmacology, 1986, v. 21, n. S2, p. 165S, doi. 10.1111/j.1365-2125.1986.tb02867.x
- Midtbo, K;
- Hals, O;
- Lauve, O;
- Meer, J;
- Storstein, L
- Article